A Study of IDN-6556 in Subjects With Liver Cirrhosis

Clinical trial NCT02230670 · COMPLETED

Trial details

NCT number: NCT02230670
Sponsor: Conatus Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Cirrhosis Hepatic Cirrhosis

Start date: 2014-08-01
Primary completion: 2016-01-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.